DNA methylation as a predictor of mepolizumab response in asthma

Koppelman, G. (Speaker)

Activiteit: Professional or public presentationProfessional

Description

1 hour online presentation to GSK genetics (USA), followed by a round table discussion with GSK leadership on genetics and anti-IL5 clinical development
Periode30-apr-2021
Gehouden opGlaxo Smith Kline, United States
Mate van erkenningInternational